ROMVIMZA

Live / Registered — Registered (as of 09 Sept 2025)

What this means for you

Registered since 09 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98817650
Registration number
7934470
Mark type
Design + words
Filed
24 Oct 2024
Published for opposition
22 Jul 2025
Registered
09 Sept 2025
Attorney of record
Karen Won

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD); Therapeutic agents, namely, kinase inhibitors

Owner

Prosecution history

  • 09 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 09 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
  • 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 22 Jul 2025 — PUBLISHED FOR OPPOSITION
  • 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 17 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 17 Jun 2025 — EXAMINER'S AMENDMENT ENTERED
  • 17 Jun 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 17 Jun 2025 — EXAMINERS AMENDMENT E-MAILED
  • 17 Jun 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 16 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 16 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 16 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 01 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 01 May 2025 — NON-FINAL ACTION E-MAILED

View this trademark record on Marksy